Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008)

被引:123
作者
Eder, Anne F. [1 ]
Herron, Ross M., Jr.
Strupp, Annie
Dy, Beth
White, Jenni
Notari, Edward P.
Dodd, Roger Y.
Benjamin, Richard J.
机构
[1] Amer Red Cross, Jerome H Holland Lab, Med Off, Biomed Serv,Natl Headquarters, Rockville, MD 20855 USA
关键词
CONSENSUS CONFERENCE; TRALI; DONORS; ANTIBODIES; IMPACT;
D O I
10.1111/j.1537-2995.2010.02652.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Plasma components from female donors were responsible for most cases of transfusion-related acute lung injury (TRALI) reported to the American Red Cross (ARC) between 2003 and 2005. Consequently, we began preferentially distributing plasma from male donors for transfusion in 2006 and evaluated the effect on reported TRALI cases in the ensuing 2 years. STUDY DESIGN AND METHODS: Suspected TRALI cases reported to the ARC Hemovigilance Program in calendar years (CY) 2006, 2007, and 2008 are described. Any case involving a fatality was also independently reviewed by three ARC physicians and classified as probable TRALI or not TRALI. RESULTS: The percentage of plasma collected from male donors and distributed for transfusion increased each year from 55% in CY2006 to 79% in CY2007 and 95% in CY2008. Independent medical review of the 77 reported TRALI cases involving a fatality identified 38 cases as probable TRALI. Plasma was the only component transfused in six of these cases in 2006, five in 2007, and zero in 2008. Overall, the analysis of reported fatalities and nonfatal cases demonstrates that TRALI involving only plasma transfusion was significantly reduced in 2008 compared to 2006 (32 vs. 7 cases; odds ratio [OR] = 0.21; 95% confidence interval [CI] = 0.08-0.45), to a level that was no longer different from the rate of TRALI observed for RBC transfusion (4.0 vs. 2.3 per 10(6) distributed components; OR = 1.78; 95% Cl = 0.67-4.36). CONCLUSIONS: Reported TRALI cases from plasma transfusion decreased in 2008 compared to the prior 2 years simultaneously with the conversion to male-predominant plasma for transfusion.
引用
收藏
页码:1732 / 1742
页数:11
相关论文
共 23 条
[1]  
AABB, 2006, AABB B
[2]  
*AABB STAND, 2006, 5421 AABB STAND
[3]   Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion [J].
Bux, J .
VOX SANGUINIS, 2005, 89 (01) :1-10
[4]   Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma [J].
Chapman, Catherine E. ;
Stainsby, Dorothy ;
Jones, Hilary ;
Love, Elizabeth ;
Massey, Edwin ;
Win, Nay ;
Navarrete, Cristina ;
Lucas, Geoff ;
Soni, Neil ;
Morgan, Cliff ;
Choo, Louise ;
Cohen, Hannah ;
Williamson, Lorna M. .
TRANSFUSION, 2009, 49 (03) :440-452
[5]   A touch of TRALI [J].
Davis, Amanda ;
Mandal, Rajni ;
Johnson, Matthew ;
Makar, Robert ;
Stowell, Christopher ;
Dzik, Sunny .
TRANSFUSION, 2008, 48 (03) :541-545
[6]   Prevalence of HLA sensitization in female apheresis donors [J].
Densmore, TL ;
Goodnough, LT ;
Ali, S ;
Dynis, M ;
Chaplin, H .
TRANSFUSION, 1999, 39 (01) :103-106
[7]   Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross [J].
Eder, Anne F. ;
Herron, Ross ;
Strupp, Annie ;
Dy, Beth ;
Notari, Edward P. ;
Chambers, Linda A. ;
Dodd, Roger Y. ;
Benjamin, Richard J. .
TRANSFUSION, 2007, 47 (04) :599-607
[8]   Measures to prevent TRALI [J].
Engelfriet, C. P. ;
Reesink, H. W. ;
Wendel, S. ;
Biagini, S. ;
Trigo, F. ;
Fontao-Wendel, R. ;
Taaning, E. ;
Jorgensen, J. ;
Riisom, K. ;
Krusius, T. ;
Koskinen, S. ;
Kretschmer, V. ;
Karger, R. ;
Lawlor, E. ;
Okazaki, H. ;
Charlewood, R. ;
Brand, A. ;
Solheim, B. G. ;
Flesland, O. ;
Letowska, M. ;
Zupanska, B. ;
Muniz-Diaz, E. ;
Senn, M. ;
Mansourri-Taleghani, B. ;
Chapman, C. E. ;
Massey, E. ;
Navarrete, C. ;
Win, N. ;
Williamson, L. M. ;
Stainsby, D. ;
Kleinman, S. ;
Kopko, P. M. ;
Silva, M. ;
Shulman, I. ;
Hollness, L. .
VOX SANGUINIS, 2007, 92 (03) :258-277
[9]  
*FDA CTR BIOL EV R, 2008, FAT REP FDA FOLL BLO
[10]   Proceedings of a consensus conference: Towards an understanding of TRALI [J].
Goldman, M ;
Webert, KE ;
Arnold, DM ;
Freedman, J ;
Hannon, J ;
Blajchman, MA .
TRANSFUSION MEDICINE REVIEWS, 2005, 19 (01) :2-31